Why is "ARVN" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-28 04:05:53
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
The Army of the Republic of Vietnam composed the ground forces of the South Vietnamese military from its inception in 1955 to the fall of Saigon on 30 April 1975. Its predecessor was the ground forces of the Vietnamese National Army, established on 8 December 1950, representing Vietnam to fight in the First Indochina War against the communist Viet Minh rebels. At the ARVN's peak, an estimated 1 in 9 citizens of South Vietnam were enlisted, composed of Regular Forces and the more voluntary Regional Forces and the Popular Force militias. It is estimated to have suffered 1,394,000 casualties during the Vietnam War.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Vanguard realignment leaves Arvinas (ARVN) ownership listed as 0 shares - stocktitan.net
-
ARVN Should I Buy - Intellectia AI
-
Arvinas, Inc. (NASDAQ:ARVN) Receives Average Rating of "Hold" from Analysts - MarketBeat
-
How The Arvinas (ARVN) Narrative Is Evolving With New Leadership And Key 2026 Pipeline Catalysts - Yahoo Finance
-
$ARVN stock is down 8% today. Here's what we see in our data. - Quiver Quantitative
-
ARVN Stock Drops On CEO Exit — Retail Is Bullish On New Chief’s Credentials, Dismisses Selloff - Stocktwits
-
Avoiding Lag: Real-Time Signals in (ARVN) Movement - Stock Traders Daily
-
BTIG Analyst Raises Price Target for Arvinas (ARVN) to $16 | ARV - GuruFocus
-
Arvinas (ARVN) CMO reports automatic RSU tax-withholding share sale - stocktitan.net
-
Here's Why We're Not Too Worried About Arvinas' (NASDAQ:ARVN) Cash Burn Situation - Yahoo Finance
-
ARVINAS ($ARVN) Releases Q4 2025 Earnings | ARVN Stock News - Quiver Quantitative
-
ARVN PE Ratio & Valuation, Is ARVN Overvalued - Intellectia AI
-
Arvinas (ARVN) settles 6,022 RSUs; insider sold 5,685 shares - stocktitan.net
-
$ARVN stock is up 14% today. Here's what we see in our data. - Quiver Quantitative
-
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
-
ARVN SEC Filings - Arvinas 10-K, 10-Q, 8-K Forms - stocktitan.net
-
Arvinas (ARVN) corrects CEO equity grant to 147,179 RSUs in Form 4/A - stocktitan.net
-
Arvinas (ARVN) director Briggs Morrison buys 20,000 common shares - stocktitan.net
-
Biotech behind first PROTAC trial taps dealmaker Randy Teel as CEO - stocktitan.net
-
Experimental Parkinson’s pill from Arvinas cuts key brain protein by 50% - stocktitan.net
-
Early ARV-102 Parkinson’s data to debut at Alzheimer’s-Parkinson’s conference - stocktitan.net
-
Arvinas, Inc. (ARVN) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
-
Arvinas (ARVN) reports positive Phase 1 ARV-102 data in Parkinson’s disease - stocktitan.net
-
Arvinas, Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials - Yahoo Finance
-
Arvinas (ARVN): Citigroup Raises Price Target to $21.00 and Main - GuruFocus
-
Arvinas (NASDAQ:ARVN) Shares Down 7.8% - What's Next? - MarketBeat
-
Discipline and Rules-Based Execution in ARVN Response - Stock Traders Daily
-
Arvinas (NASDAQ:ARVN) Trading Down 7.8% - What's Next? - MarketBeat
-
Noah Berkowitz Sells 6,435 Shares of Arvinas (NASDAQ:ARVN) Stock - MarketBeat
-
Arvinas (Nasdaq: ARVN) posts $41.9M Q3 revenue; FDA accepts vepdegestrant NDA - stocktitan.net
-
Arvinas (ARVN) grants CMO 67,000 options and 45,000 RSUs - stocktitan.net
-
Briggs Morrison Acquires 20,000 Shares of Arvinas (NASDAQ:ARVN) Stock - MarketBeat
-
Ngo Dinh Diem and the Army of the Republic of Vietnam - Britannica
-
Companies Like Arvinas (NASDAQ:ARVN) Are In A Position To Invest In Growth - simplywall.st
-
Arvinas (NASDAQ:ARVN) Price Target Raised to $21.00 at Citigroup - MarketBeat
-
Arvinas (NASDAQ:ARVN) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
-
Wall Street Analysts Think Arvinas (ARVN) Could Surge 25.57%: Read This Before Placing a Bet - Yahoo Finance
-
Earnings To Watch: Arvinas Inc (ARVN) Reports Q3 2025 Result - Yahoo Finance
-
Arvinas cuts costs, holds $685M ahead of June FDA breast cancer ruling - stocktitan.net
-
Ngo Quang Truong South Vietnam ARVN - HistoryNet
-
Vanguard Group Inc. Trims Position in Arvinas, Inc. $ARVN - MarketBeat
-
$100M Cost Savings: Arvinas Restructures, Out-Licenses Cancer Drug & Launches Major Share Buyback - stocktitan.net
-
Arvinas (NASDAQ:ARVN) Sets New 12-Month High on Insider Buying Activity - MarketBeat
-
Arvinas (ARVN) director auto-sells shares to cover RSU tax obligations - stocktitan.net
-
Arvinas (ARVN) Reports Promising Phase 1 Trial Results for ARV-102 in Parkinson's Disease - GuruFocus
-
Arvinas (ARVN) VP awarded stock options and RSUs with 4-year vesting - stocktitan.net
-
Arvinas (ARVN): Losses Accelerate 7.7% Annually, but Stock Trades at Peer-Low 1.9x Sales - Yahoo Finance
-
Citigroup Raises Price Target for Arvinas (ARVN) to $18.00 | ARV - GuruFocus
-
Insider Sale: Chief Scientific Officer of $ARVN Sells 4,592 Shares - Quiver Quantitative
-
Piper Sandler Raises Price Target on Arvinas (ARVN) to $20.00 | - GuruFocus
-
Arbiter Partners Capital Management LLC Invests $3.86 Million in Arvinas, Inc. $ARVN - MarketBeat
-
Arvinas Inc (ARVN) Q3 2025 Earnings Call Highlights: Clinical Advancements and Strategic ... - Yahoo Finance
-
ARVN Stock: Citigroup Upgrades Arvinas to 'Buy' with 50% Target - GuruFocus
-
Arvinas Stock Pre-Market (+4.7%): Broad Biotech Rally on Geopolitical De-escalation, Falling Oil - Trefis
-
ARVN: Evercore ISI Raises Price Target to $19, Maintains Outperf - GuruFocus
-
Arvinas, Inc. (ARVN) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
-
Possible Bearish Signals With Arvinas Insiders Disposing Stock - simplywall.st
-
Arvinas (NASDAQ:ARVN) Given New $18.00 Price Target at Citigroup - MarketBeat
-
Is Arvinas Stock Built to Withstand More Downside? - Trefis
-
Goldman Sachs Downgrades Arvinas (ARVN) to 'Sell', Lowers Price Target | ARVN Stock News - GuruFocus
-
[144] ARVINAS, INC. SEC Filing - stocktitan.net
-
Arvinas (ARVN) Set to Announce Q4 Earnings Amid Mixed Expectatio - GuruFocus
-
Arvinas (NASDAQ:ARVN) Director John Houston Sells 35,297 Shares - MarketBeat
-
Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 - GlobeNewswire
-
Investors in Arvinas (NASDAQ:ARVN) have unfortunately lost 86% over the last three years - Yahoo Finance
-
Wedbush Maintains Neutral on Arvinas, Inc. (ARVN) Feb 24, 2026 - Meyka
-
Arvinas (ARVN) Reports Significant Revenue Decline and Sets Ambi - GuruFocus
-
Arvinas, Inc. to Participate in Four Upcoming Investor Conferences in March 2026 - Quiver Quantitative
-
Wells Fargo Maintains Arvinas(ARVN.US) With Buy Rating, Cuts Target Price to $15 - 富途牛牛
-
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS), High Tide (HITI) and Arvinas Holding Company (ARVN) - The Globe and Mail
-
Arvinas: A Potential 'Sum Of The Parts' Story (NASDAQ:ARVN) - Seeking Alpha
-
Arvinas (ARVN) Reports Significant Revenue Decline in Q4 - GuruFocus
-
Behavioral Patterns of ARVN and Institutional Flows - Stock Traders Daily
-
Arvinas (ARVN): Wedbush Maintains Neutral Rating and Raises Pric - GuruFocus
-
Wedbush Maintains Arvinas(ARVN.US) With Hold Rating, Raises Target Price to $11 - 富途牛牛
-
Regulatory Turbulence: How FDA Disruptions and Budget Cuts Threaten Arvinas Holding Company’s Drug Development Timelines - The Globe and Mail
-
Citi Reaffirms Their Buy Rating on Arvinas Holding Company (ARVN) - The Globe and Mail
-
First-Ever PROTAC Cancer Drug Heads to FDA: Arvinas' Breakthrough Breast Cancer Treatment - stocktitan.net
-
Arvinas (ARVN) Projects Financial Stability into Late 2028 - GuruFocus
-
ARVN veterans to be honored - orange county tribune
-
Arvinas, Inc. to Host Webcast Reviewing Q4 and Full Year 2025 Financial Results on February 24, 2026 - Quiver Quantitative
-
Arvinas (ARVN) Appoints New CEO as Leadership Changes Unfold - GuruFocus
-
Arvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ... - Yahoo Finance
-
Arvinas (NASDAQ:ARVN) CAO David Loomis Sells 1,016 Shares - MarketBeat
-
Arvinas (ARVN) Soars 14% as Investors Cheer Pipeline Reset and Jefferies Update - TechStock²
-
Arvinas (NASDAQ: ARVN) Reports ≥30% Tumor Reductions with ARV-806 in KRAS G12D Models - stocktitan.net
-
Analysts Conflicted on These Healthcare Names: Akebia Therapeutics (AKBA), Idexx Laboratories (IDXX) and Arvinas Holding Company (ARVN) - The Globe and Mail
-
Arvinas's Earnings Outlook - Benzinga
-
The M113 entered Army service in 1961, featuring light aluminum armor that could protect its crew against small arms fire and shrapnel. In April 1962 the South Vietnamese, right, began receiving M113s, which the shocked Viet Cong dubbed “Green Dragons.” - HistoryNet
-
HC Wainwright Estimates Arvinas' Q1 Earnings (NASDAQ:ARVN) - MarketBeat
-
Arvinas (ARVN) Q4 2025 Earnings Call Transcript - The Globe and Mail
-
5 Analysts Assess Arvinas: What You Need To Know - Benzinga
-
Insider Buying: Briggs Morrison Acquires 30,000 Shares of Arvinas Inc (ARVN) - GuruFocus
-
Arvinas Announces Leadership Transition and New CEO Appointment - TipRanks
-
Arvinas, Inc. (ARVN): Among Stocks Under $10 that Will Triple - Yahoo Finance
-
Arvinas Reveals Promising Preclinical Data for ARV-393 - TipRanks
-
Protein Degradation Pioneer Arvinas Announces Q1 2025 Earnings Date and Webcast Details - stocktitan.net
-
Arvinas (ARVN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
-
Breakthrough Cancer Treatment ARV-393 Demonstrates Powerful Results Against Lymphoma in Latest Research - stocktitan.net
-
Arvinas, Inc. (ARVN) Surprises with Q1 Earnings Beat: But Why is the Stock Down? - ragingbull.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.